Stockreport

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Sanofi SNY announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation to Waylirz (rilzabrutinib) for the treatment of IgG4 [Read more]